Groundbreaking DNA Technique Used in Britain to Help Prevent Inherited Diseases
Introduction
A groundbreaking new technique has been used in Britain to help eight healthy babies be born with the DNA of three people. This experimental method has been used to prevent inherited diseases and has already shown promising results. This is a major step forward in the field of reproductive technology and has the potential to change the lives of many families.
Key Details
The technique involves taking the nucleus of an egg from a woman with known genetic defects and transferring it to a donor egg. This donor egg has had its own nucleus removed, leaving behind the healthy mitochondrial DNA. The fertilized egg is then implanted into the mother to carry to term. This method has been used in previous cases, resulting in five babies born with this technique in Mexico. However, this is the first time it has been successfully used in Britain.
Impact
This breakthrough has the potential to help families who have a history of inherited diseases. It also provides hope for those who have struggled with infertility. However, there are ethical concerns surrounding this technique, as it involves the manipulation of human DNA. The long-term effects of this method are still unknown and further research and regulation is needed to ensure the safety and ethical implications of this technique. Nonetheless, this is a major step forward in the fight against inherited diseases and brings new hope for families who have been affected by them.
About the Organizations Mentioned
OpenAI
OpenAI is a leading artificial intelligence research and deployment company founded in 2015 with the mission to ensure that artificial general intelligence (AGI)—AI systems generally smarter than humans—benefits all of humanity[1][2]. Initially established as a nonprofit, OpenAI’s goal has always been to advance safe and broadly beneficial AI technologies. In 2019, OpenAI created a for-profit subsidiary to scale its research and deployment efforts while keeping mission-aligned governance. As of October 2025, this structure evolved into the OpenAI Foundation (nonprofit) governing the OpenAI Group, a public benefit corporation (PBC). This unique corporate form legally binds OpenAI Group to prioritize its mission alongside commercial success, ensuring broader stakeholder interests are considered[1]. The Foundation holds equity in the Group, aligning incentives for long-term impact and growth. Microsoft owns approximately 27% of OpenAI Group, with employees and investors holding the rest[1]. OpenAI is renowned for pioneering breakthroughs in large language models and AI applications. Its products like ChatGPT revolutionized human-computer interaction by enabling natural language conversations and task automation. OpenAI continuously innovates by integrating AI into business tools—for example, its recent launch of “company knowledge” in ChatGPT Business harnesses AI to aggregate and analyze internal company data from apps like Slack, Google Drive, and GitHub, enhancing workplace productivity and decision-making[3]. Key achievements include advancing AI safety research, reducing hallucinations in language models, and expanding AI’s accessibility through products like Codex and ChatGPT Atlas (a browser with ChatGPT integration)[2]. OpenAI’s balanced governance model and cutting-edge research position it uniquely at the intersection of technology innovation and ethical AI development, making it a focal point in business and technology news globally.
